Anna Passera

403 total citations
7 papers, 82 citations indexed

About

Anna Passera is a scholar working on Dermatology, Surgery and Epidemiology. According to data from OpenAlex, Anna Passera has authored 7 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Dermatology, 3 papers in Surgery and 2 papers in Epidemiology. Recurrent topics in Anna Passera's work include Hidradenitis Suppurativa and Treatments (4 papers), Colorectal and Anal Carcinomas (2 papers) and Chemotherapy-related skin toxicity (1 paper). Anna Passera is often cited by papers focused on Hidradenitis Suppurativa and Treatments (4 papers), Colorectal and Anal Carcinomas (2 papers) and Chemotherapy-related skin toxicity (1 paper). Anna Passera collaborates with scholars based in United States, Switzerland and Germany. Anna Passera's co-authors include Esther van den Berg, Odd Erik Johansen, C. Verhagen, Geert Jan Biessels, Jyothis T. George, Sven Schnaidt, Bernard Zinman, Julio Rosenstock, Maria Teresa Illeni and Marc Vandemeulebroecke and has published in prestigious journals such as Diabetes Care, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Anna Passera

6 papers receiving 81 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Anna Passera	41	19	16	15	14	7	82
Agnes A. Mooslechner	33 0.8×	5 0.3×	12 0.8×	12 0.8×	24 1.7×	13	125
Metin Yeşiltepe	12 0.3×	7 0.4×	25 1.6×	9 0.6×	6 0.4×	13	77
A. Chu	36 0.9×	3 0.2×	20 1.3×	12 0.8×	17 1.2×	5	107
Antoni Palasí	22 0.5×	14 0.7×	17 1.1×	7 0.5×	2 0.1×	11	121
Zoi Aidoni	8 0.2×	9 0.5×	20 1.3×	12 0.8×	26 1.9×	13	99
Miroslav Gjurašin	14 0.3×	4 0.2×	18 1.1×	6 0.4×	52 3.7×	11	117
Marimar Freijó	15 0.4×	6 0.3×	8 0.5×	21 1.4×	16 1.1×	13	98
Pauline Genter	92 2.2×	6 0.3×	25 1.6×	34 2.3×	28 2.0×	13	225
Keiichiro Kosuge	56 1.4×	8 0.4×	22 1.4×	18 1.2×	28 2.0×	7	115

Countries citing papers authored by Anna Passera

Since Specialization

Citations

This map shows the geographic impact of Anna Passera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Passera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Passera more than expected).

Fields of papers citing papers by Anna Passera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Passera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Passera. The network helps show where Anna Passera may publish in the future.

Co-authorship network of co-authors of Anna Passera

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Passera. A scholar is included among the top collaborators of Anna Passera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Passera. Anna Passera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Ingram, John R, Magdalena B. Wozniak, Anna Passera, et al.. (2025). The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa. British Journal of Dermatology. 193(6). 1155–1164.

Porter, Martina L., Gerard Bruin, Magdalena B. Wozniak, et al.. (2024). 52241 Secukinumab demonstrates low immunogenicity in patients with moderate-to-severe hidradenitis suppurativa: Results from placebo-controlled, double-blind, Phase 3 SUNSHINE and SUNRISE trials. Journal of the American Academy of Dermatology. 91(3). AB84–AB84. 1 indexed citations

Passera, Anna, Elisa Muscianisi, David Demanse, et al.. (2024). New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the SUNSHINE and SUNRISE trials. Journal of the European Academy of Dermatology and Venereology. 39(8). 1410–1420. 4 indexed citations

Wei, Xiaoling, Anna Passera, Elisa Muscianisi, et al.. (2023). Assessing the validity and clinical meaningfulness of skin pain response (NRS30) assessed using numerical rating scale in hidradenitis suppurativa: Results from the SUNSHINE and SUNRISE trials. Journal of the American Academy of Dermatology. 89(6). 1285–1287. 3 indexed citations

Verhagen, C., Esther van den Berg, Christoph Wanner, et al.. (2022). Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk. Journal of Diabetes and its Complications. 36(10). 108303–108303. 3 indexed citations

Biessels, Geert Jan, C. Verhagen, Esther van den Berg, et al.. (2019). Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial. Diabetes Care. 42(10). 1930–1938. 62 indexed citations

Illeni, Maria Teresa, et al.. (1994). Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.. PubMed. 44(12A). 1503–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact